GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » Research & Development

3B BlackBio Dx (BOM:532067) Research & Development : ₹0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. 3B BlackBio Dx's Research & Development for the three months ended in Mar. 2024 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.0 Mil.


3B BlackBio Dx Research & Development Historical Data

The historical data trend for 3B BlackBio Dx's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx Research & Development Chart

3B BlackBio Dx Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.06 2.51 3.62 8.45 -

3B BlackBio Dx Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

3B BlackBio Dx Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3B BlackBio Dx  (BOM:532067) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


3B BlackBio Dx Research & Development Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines